More tools:Markets·Screener·Research·Chat

Pharvaris N.V. Ordinary Shares (PHVS) Financial Statements

Pharvaris N.V. Ordinary Shares
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00YYCW2H3
XNAS · usd
37.84▲ 2.59 (7.35%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close35.25
Day's Range37.60 – 43.25
52-Week Range20.65 – 43.25
Volume6.3M
Avg Volume755.7K
Share Statistics
Shares Outstanding
Employees129
ExchangeXNAS
Listed2021-02-05
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Pharvaris N.V. Ordinary Shares (PHVS)
What is Pharvaris N.V. Ordinary Shares's Market Cap?
Pharvaris N.V. Ordinary Shares's Market Cap is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Enterprise Value?
Pharvaris N.V. Ordinary Shares's Enterprise Value is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's EV / EBITDA?
Pharvaris N.V. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Net Income (TTM)?
Pharvaris N.V. Ordinary Shares's Net Income (TTM) is -$206.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's EBITDA?
Pharvaris N.V. Ordinary Shares's EBITDA is -$203.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Diluted EPS (TTM)?
Pharvaris N.V. Ordinary Shares's Diluted EPS (TTM) is -3.16, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Net Debt?
Pharvaris N.V. Ordinary Shares's Net Debt is -$342.3M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Profit or loss [abstract]
Research and development expenses
General and administrative expenses
Total operating expenses
Finance (expenses) income
Loss before income tax
Income tax expense
Net Loss